231 related articles for article (PubMed ID: 19150104)
1. Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle.
Simon M; Johansson C; Lundkvist A; Mirazimi A
Virology; 2009 Mar; 385(2):313-22. PubMed ID: 19150104
[TBL] [Abstract][Full Text] [Related]
2. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent.
Simon M; Johansson C; Mirazimi A
J Gen Virol; 2009 Jan; 90(Pt 1):210-5. PubMed ID: 19088291
[TBL] [Abstract][Full Text] [Related]
3. Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells.
Andersson I; Simon M; Lundkvist A; Nilsson M; Holmström A; Elgh F; Mirazimi A
J Med Virol; 2004 Jan; 72(1):83-93. PubMed ID: 14635015
[TBL] [Abstract][Full Text] [Related]
4. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response.
Andersson I; Karlberg H; Mousavi-Jazi M; Martínez-Sobrido L; Weber F; Mirazimi A
J Med Virol; 2008 Aug; 80(8):1397-404. PubMed ID: 18551619
[TBL] [Abstract][Full Text] [Related]
5. In situ rolling circle amplification detection of Crimean Congo hemorrhagic fever virus (CCHFV) complementary and viral RNA.
Andersson C; Henriksson S; Magnusson KE; Nilsson M; Mirazimi A
Virology; 2012 May; 426(2):87-92. PubMed ID: 22341783
[TBL] [Abstract][Full Text] [Related]
6. Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells.
Connolly-Andersen AM; Magnusson KE; Mirazimi A
J Virol; 2007 Mar; 81(5):2158-64. PubMed ID: 17166898
[TBL] [Abstract][Full Text] [Related]
7. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells.
Andersson I; Lundkvist A; Haller O; Mirazimi A
J Med Virol; 2006 Feb; 78(2):216-22. PubMed ID: 16372299
[TBL] [Abstract][Full Text] [Related]
8. Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus.
Simon M; Falk KI; Lundkvist A; Mirazimi A
Virus Res; 2006 Sep; 120(1-2):184-90. PubMed ID: 16632039
[TBL] [Abstract][Full Text] [Related]
9. Novel one-step real-time RT-PCR assay for rapid and specific diagnosis of Crimean-Congo hemorrhagic fever encountered in the Balkans.
Duh D; Saksida A; Petrovec M; Dedushaj I; Avsic-Zupanc T
J Virol Methods; 2006 May; 133(2):175-9. PubMed ID: 16343650
[TBL] [Abstract][Full Text] [Related]
10. Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins.
Haferkamp S; Fernando L; Schwarz TF; Feldmann H; Flick R
Virol J; 2005 Apr; 2():42. PubMed ID: 15850490
[TBL] [Abstract][Full Text] [Related]
11. Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.
Bertolotti-Ciarlet A; Smith J; Strecker K; Paragas J; Altamura LA; McFalls JM; Frias-Stäheli N; García-Sastre A; Schmaljohn CS; Doms RW
J Virol; 2005 May; 79(10):6152-61. PubMed ID: 15858000
[TBL] [Abstract][Full Text] [Related]
12. The complete genome analysis of Crimean-Congo hemorrhagic fever virus isolated in Turkey.
Ozdarendeli A; Canakoğlu N; Berber E; Aydin K; Tonbak S; Ertek M; Buzgan T; Bolat Y; Aktaş M; Kalkan A
Virus Res; 2010 Feb; 147(2):288-93. PubMed ID: 19941917
[TBL] [Abstract][Full Text] [Related]
13. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus.
Andersson I; Bladh L; Mousavi-Jazi M; Magnusson KE; Lundkvist A; Haller O; Mirazimi A
J Virol; 2004 Apr; 78(8):4323-9. PubMed ID: 15047845
[TBL] [Abstract][Full Text] [Related]
14. Bacterial expression of Crimean-Congo hemorrhagic fever virus nucleoprotein and its evaluation as a diagnostic reagent in an indirect ELISA.
Samudzi RR; Leman PA; Paweska JT; Swanepoel R; Burt FJ
J Virol Methods; 2012 Jan; 179(1):70-6. PubMed ID: 22001274
[TBL] [Abstract][Full Text] [Related]
15. Evolution of Crimean-Congo Hemorrhagic Fever virus.
Anagnostou V; Papa A
Infect Genet Evol; 2009 Sep; 9(5):948-54. PubMed ID: 19560561
[TBL] [Abstract][Full Text] [Related]
16. A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.
Devignot S; Bergeron E; Nichol S; Mirazimi A; Weber F
J Virol; 2015 Jun; 89(11):5957-67. PubMed ID: 25810550
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of the M RNA segment of Crimean-Congo hemorrhagic fever virus strains involved in the recent outbreaks in Russia.
Kuhn JH; Seregin SV; Morzunov SP; Petrova ID; Vyshemirskii OI; Lvov DK; Tyunnikov GI; Gutorov VV; Netesov SV; Petrov VS
Arch Virol; 2004 Nov; 149(11):2199-213. PubMed ID: 15503207
[TBL] [Abstract][Full Text] [Related]
18. Development of a TaqMan minor groove binding protein assay for the detection and quantification of Crimean-Congo hemorrhagic fever virus.
Garrison AR; Alakbarova S; Kulesh DA; Shezmukhamedova D; Khodjaev S; Endy TP; Paragas J
Am J Trop Med Hyg; 2007 Sep; 77(3):514-20. PubMed ID: 17827370
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles.
Zivcec M; Metcalfe MG; Albariño CG; Guerrero LW; Pegan SD; Spiropoulou CF; Bergeron É
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004259. PubMed ID: 26625182
[TBL] [Abstract][Full Text] [Related]
20. Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells.
Connolly-Andersen AM; Douagi I; Kraus AA; Mirazimi A
Virology; 2009 Aug; 390(2):157-62. PubMed ID: 19570561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
